+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Blood Glucose Test Strips Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • May 2021
  • Region: Global
  • TechNavio
  • ID: 5351689
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the blood glucose test strips market and it is poised to grow by $6.77 bn during 2021-2025, progressing at a CAGR of almost 10% during the forecast period. The report on blood glucose test strips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in the number of diabetes cases and rising awareness about diabetes and growth of new marketing strategies In addition, increase in the number of diabetes cases and rising awareness about diabetes is anticipated to boost the growth of the market as well.

The blood glucose test strips market analysis includes end-user segment and geographic landscape.

The blood glucose test strips market is segmented as below:

By End-user
  • Hospitals and diagnostic laboratories
  • Home care settings
  • POL

By Geography
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the availability of products on online channels as one of the prime reasons driving the blood glucose test strips market growth during the next few years.

The report on blood glucose test strips market covers the following areas:
  • Blood glucose test strips market sizing
  • Blood glucose test strips market forecast
  • Blood glucose test strips market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood glucose test strips market vendors that include Abbott Laboratories, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., LifeScan IP Holdings LLC, Omnis Health LLC, Sanofi SA, Sinocare Inc., Teladoc Health Inc., and UniStrip Technologies LLC. Also, the blood glucose test strips market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user
  • Market segments
  • Comparison by End-user
  • Hospitals and diagnostic laboratories - Market size and forecast 2020-2025
  • Home care settings - Market size and forecast 2020-2025
  • POL - Market size and forecast 2020-2025
  • Market opportunity by End-user

Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • F. Hoffmann-La Roche Ltd.
  • LifeScan IP Holdings LLC
  • Omnis Health LLC
  • Sanofi SA
  • Sinocare Inc.
  • Teladoc Health Inc.
  • UniStrip Technologies LLC

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • End user - Market share 2020-2025 (%)
  • Comparison by End user
  • Hospitals and diagnostic laboratories - Market size and forecast 2020-2025 ($ million)
  • Hospitals and diagnostic laboratories - Year-over-year growth 2020-2025 (%)
  • Home care settings - Market size and forecast 2020-2025 ($ million)
  • Home care settings - Year-over-year growth 2020-2025 (%)
  • POL - Market size and forecast 2020-2025 ($ million)
  • POL - Year-over-year growth 2020-2025 (%)
  • Market opportunity by End user
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Key customers
  • Abbott Laboratories - Segment focus
  • Ascensia Diabetes Care Holdings AG - Overview
  • Ascensia Diabetes Care Holdings AG - Product and service
  • Ascensia Diabetes Care Holdings AG - Key offerings
  • Ascensia Diabetes Care Holdings AG - Key customers
  • Ascensia Diabetes Care Holdings AG - Segment focus
  • B. Braun Melsungen AG - Overview
  • B. Braun Melsungen AG - Business segments
  • B. Braun Melsungen AG - Key offerings
  • B. Braun Melsungen AG - Key customers
  • B. Braun Melsungen AG - Segment focus
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Business segments
  • F. Hoffmann-La Roche Ltd. - Key offerings
  • F. Hoffmann-La Roche Ltd. - Key customers
  • F. Hoffmann-La Roche Ltd. - Segment focus
  • LifeScan IP Holdings LLC - Overview
  • LifeScan IP Holdings LLC - Product and service
  • LifeScan IP Holdings LLC - Key offerings
  • LifeScan IP Holdings LLC - Key customers
  • LifeScan IP Holdings LLC - Segment focus
  • Omnis Health LLC - Overview
  • Omnis Health LLC - Product and service
  • Omnis Health LLC - Key offerings
  • Omnis Health LLC - Key customers
  • Omnis Health LLC - Segment focus
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key offerings
  • Sanofi SA - Key customers
  • Sanofi SA - Segment focus
  • Sinocare Inc. - Overview
  • Sinocare Inc. - Product and service
  • Sinocare Inc. - Key offerings
  • Sinocare Inc. - Key customers
  • Sinocare Inc. - Segment focus
  • Teladoc Health Inc. - Overview
  • Teladoc Health Inc. - Business segments
  • Teladoc Health Inc. - Key offerings
  • Teladoc Health Inc. - Key customers
  • Teladoc Health Inc. - Segment focus
  • UniStrip Technologies LLC - Overview
  • UniStrip Technologies LLC - Product and service
  • UniStrip Technologies LLC - Key offerings
  • UniStrip Technologies LLC - Key customers
  • UniStrip Technologies LLC - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global blood glucose test strips market: Abbott Laboratories, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., LifeScan IP Holdings LLC, Omnis Health LLC, Sanofi SA, Sinocare Inc., Teladoc Health Inc., and UniStrip Technologies LLC.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the availability of products on online channels.'

According to the report, one of the major drivers for this market is the increase in the number of diabetes cases and rising awareness about diabetes.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • F. Hoffmann-La Roche Ltd.
  • LifeScan IP Holdings LLC
  • Omnis Health LLC
  • Sanofi SA
  • Sinocare Inc.
  • Teladoc Health Inc.
  • UniStrip Technologies LLC